Kraig Biocraft Laboratories, Inc financial data

Symbol
KBLB on OTC
Location
2723 South State Street, Suite 150, Ann Arbor, MI
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 12, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 9.26 % -54.6%
Quick Ratio 0.13 % +66%
Debt-to-equity -121 % +13.2%
Return On Equity 54.1 % -8.2%
Return On Assets -264 % -74.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.04B shares +0.41%
Entity Public Float 133M USD +214%
Weighted Average Number of Shares Outstanding, Basic 1.07B shares +2.88%
Weighted Average Number of Shares Outstanding, Diluted 1.07B shares +2.88%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 158K USD -10.7%
General and Administrative Expense 2.13M USD -5.84%
Operating Income (Loss) -3.37M USD +5.04%
Nonoperating Income (Expense) -319K USD +1.78%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -3.69M USD +4.77%
Net Income (Loss) Attributable to Parent -4.47M USD -15.5%
Earnings Per Share, Basic 0 USD/shares
Earnings Per Share, Diluted 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.57M USD +31.6%
Inventory, Net 29.1K USD +322%
Assets, Current 1.64M USD +32.5%
Property, Plant and Equipment, Net 31K USD -33.4%
Operating Lease, Right-of-Use Asset 184K USD +86.5%
Assets 2.36M USD +16.3%
Accrued Liabilities, Current 191K USD
Liabilities, Current 10.2M USD +9.03%
Operating Lease, Liability, Noncurrent 128K USD +201%
Liabilities 10.3M USD +9.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax 13K USD
Retained Earnings (Accumulated Deficit) -55.9M USD -7.06%
Stockholders' Equity Attributable to Parent -7.96M USD -8.14%
Liabilities and Equity 2.36M USD +16.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -434K USD +11.2%
Net Cash Provided by (Used in) Financing Activities 158K USD
Common Stock, Shares, Issued 2.16M shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -276K USD +45.2%
Deferred Tax Assets, Valuation Allowance 5.34M USD +9.32%
Operating Lease, Liability 184K USD +83.9%
Depreciation 23.6K USD -14.9%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -3.87M USD +23%
Lessee, Operating Lease, Liability, to be Paid 212K USD +85%
Operating Lease, Liability, Current 56.1K USD -2.53%
Lessee, Operating Lease, Liability, to be Paid, Year Two 61.4K USD +367%
Lessee, Operating Lease, Liability, to be Paid, Year One 63.7K USD +23.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 28K USD +92.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 50.2K USD +533%
Deferred Tax Assets, Operating Loss Carryforwards 5.34M USD +9.32%
Preferred Stock, Shares Issued 0 shares
Lessee, Operating Lease, Liability, to be Paid, Year Four 8.71K USD -66.7%
Operating Lease, Payments 15.9K USD +18.7%
Additional Paid in Capital 12.3M USD +0.91%
Preferred Stock, Shares Outstanding 0 shares